# info@crystallizationsummit.com
English

Office Address

  • info@crystallizationsummit.com
  • Phone: +1 732-978-0828

Pinterest

Social List

News Right Sidebar

2024 , 2024-speakers , session-2-particle-engineering-to-address-formulation-challenge

Dr. Lotfi Derdour, GlaxoSmithKline

June 21, 2024
2024 , session-3-computational-applications-for-controlled-crystallization

Solid Form Design and Selection Utilizing Combined Experimental and Computational Techniques

May 22, 2024
2024 , session-3-computational-applications-for-controlled-crystallization

Dr. Rajni Miglani Bhardwaj, Pfizer

May 22, 2024
2024 , session-3-computational-applications-for-controlled-crystallization

Computer-aided solid form design: Current challenges, future opportunities

May 22, 2024
2024 , session-3-computational-applications-for-controlled-crystallization

Dr. Susan M. Reutzel-Edens, SuRE Pharma Consulting, LLC

May 22, 2024
2024 , session-3-computational-applications-for-controlled-crystallization

Crystal structure prediction for realistic pharmaceutical targets with AIMNet2 neural network potential

May 19, 2024
session-3-computational-applications-for-controlled-crystallization

Prof. Olexandr Isayev, Carneige Mellon University

May 19, 2024
2024 , session-3-computational-applications-for-controlled-crystallization

Fast-tracking Pharmaceutical Process Optimization with Small Data and Machine Learning

May 19, 2024
2024 , session-2-particle-engineering-to-address-formulation-challenge

Use of automation, dynamic image analysis, and process analytical technologies to enable data rich particle engineering efforts at the Drug Substance / Drug Product interface: A case study using Lovastatin

May 19, 2024
session-2-particle-engineering-to-address-formulation-challenge

Dr. Jeremy M. Merritt, Eli Lilly & Co.

May 19, 2024
RSS
Follow by Email
Facebook
Twitter
LinkedIn
Share